Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques

Britt Marie Swahn*, David Wensbo, Johan Sandell, Daniel Sohn, Can Slivo, David Pyring, Jonas Malmström, Erwan Arzel, Michaela Vallin, Margareta Bergh, Fredrik Jeppsson, Allan E. Johnson, Anders Juréus, Jan Neelissen, Samuel Svensson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

The syntheses and SAR of new series of β-amyloid binding agents are reported. The effort to optimize signal-to-background ratios for these ligands are described. Compounds 8, 21 and 30 displayed desirable lipophilicity and pharmacokinetic properties. Compounds 8 and 21 were evaluated with in vitro autoradiographic studies and in vivo in APP/PS1 transgenic mice. It is shown that it was possible to increase the signal-to-background ratios compared to PIB 1, as demonstrated by compounds 8 and 21.

Original languageEnglish (US)
Pages (from-to)1976-1980
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume20
Issue number6
DOIs
StatePublished - Mar 15 2010
Externally publishedYes

Keywords

  • 2-Pyridylbenzofuran
  • 2-Pyridylbenzothiazole
  • 2-Pyridylbenzoxazole
  • Alzheimer
  • Carbon-11
  • Positron emission tomography, PET
  • β-Amyloid plaque

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques'. Together they form a unique fingerprint.

Cite this